雌二醇测量的准确度测试。

IF 2.5 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinical biochemistry Pub Date : 2023-12-01 DOI:10.1016/j.clinbiochem.2023.110700
Zhimin Tim Cao , Robert Rej , Hubert Vesper , J. Rex Astles
{"title":"雌二醇测量的准确度测试。","authors":"Zhimin Tim Cao ,&nbsp;Robert Rej ,&nbsp;Hubert Vesper ,&nbsp;J. Rex Astles","doi":"10.1016/j.clinbiochem.2023.110700","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Accuracy of estradiol measurements is important but conventional proficiency testing (PT) cannot assess accuracy when possibly non-commutable samples are used and method peer-group means are the targets. Accuracy-based assessment of estradiol measurements is needed.</p></div><div><h3>Design and Methods</h3><p>Five serum samples were prepared from single donors, frozen, and distributed overnight to 76 New York State Department of Health (NYSDOH)-certified laboratories. Participants analyzed samples for estradiol. The biases of group means were assessed against the Centers for Disease Control and Prevention (CDC)-defined targets, evaluated using the Hormone Standardization Program (HoSt) E2 performance criterion of ±12.5 %. Each laboratory’s performance was evaluated using total allowable error (acceptance limits) of target ±25 % or ±15 pg/mL (55 pmol/L) (whichever was greater, NYSDOH), target ±30 % (Clinical Laboratory Improvement Amendments [CLIA]), and target ±26 % (minimal limit based on biological variation [BV]).</p></div><div><h3>Results</h3><p>The biases (range) were 34 % (−17 % to 175 %), 40 % (−33 % to 386 %), 16 % (−45 % to 193 %), 5 % (−27 % to 117 %), and −4% (−31 % to 21 %), for samples at estradiol of 24.1, 28.4, 61.7, 94.1, and 127 pg/mL, or 89, 104, 227, 345, and 466 pmol/L, respectively. Large positive method/analytical systematic biases were revealed for 9 commonly used method/analytical systems in the United States at low estradiol concentrations. Of the 9 analytical systems, 0, 0, 3, 7 and 6 met the HoSt criterion for the samples with estradiol at the five respective concentrations. PT evaluation showed that 59 %, 69 % and 87 % of laboratories would receive a PT event passing (satisfactory) score when the CDC-defined target and a criterion of NYSDOH, CLIA or BV was used, respectively. However, &gt;95 % laboratories would obtain PT passing score if method peer-group means were used as targets regardless of the criterion used.</p></div><div><h3>Conclusions</h3><p>Improvement in accuracy of estradiol measurements is needed, particularly at low estradiol concentrations. Accuracy-based PT provides unambiguous information about the accuracy of methods/analytical systems.</p></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Accuracy-based proficiency testing for estradiol measurements\",\"authors\":\"Zhimin Tim Cao ,&nbsp;Robert Rej ,&nbsp;Hubert Vesper ,&nbsp;J. Rex Astles\",\"doi\":\"10.1016/j.clinbiochem.2023.110700\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Accuracy of estradiol measurements is important but conventional proficiency testing (PT) cannot assess accuracy when possibly non-commutable samples are used and method peer-group means are the targets. Accuracy-based assessment of estradiol measurements is needed.</p></div><div><h3>Design and Methods</h3><p>Five serum samples were prepared from single donors, frozen, and distributed overnight to 76 New York State Department of Health (NYSDOH)-certified laboratories. Participants analyzed samples for estradiol. The biases of group means were assessed against the Centers for Disease Control and Prevention (CDC)-defined targets, evaluated using the Hormone Standardization Program (HoSt) E2 performance criterion of ±12.5 %. Each laboratory’s performance was evaluated using total allowable error (acceptance limits) of target ±25 % or ±15 pg/mL (55 pmol/L) (whichever was greater, NYSDOH), target ±30 % (Clinical Laboratory Improvement Amendments [CLIA]), and target ±26 % (minimal limit based on biological variation [BV]).</p></div><div><h3>Results</h3><p>The biases (range) were 34 % (−17 % to 175 %), 40 % (−33 % to 386 %), 16 % (−45 % to 193 %), 5 % (−27 % to 117 %), and −4% (−31 % to 21 %), for samples at estradiol of 24.1, 28.4, 61.7, 94.1, and 127 pg/mL, or 89, 104, 227, 345, and 466 pmol/L, respectively. Large positive method/analytical systematic biases were revealed for 9 commonly used method/analytical systems in the United States at low estradiol concentrations. Of the 9 analytical systems, 0, 0, 3, 7 and 6 met the HoSt criterion for the samples with estradiol at the five respective concentrations. PT evaluation showed that 59 %, 69 % and 87 % of laboratories would receive a PT event passing (satisfactory) score when the CDC-defined target and a criterion of NYSDOH, CLIA or BV was used, respectively. However, &gt;95 % laboratories would obtain PT passing score if method peer-group means were used as targets regardless of the criterion used.</p></div><div><h3>Conclusions</h3><p>Improvement in accuracy of estradiol measurements is needed, particularly at low estradiol concentrations. Accuracy-based PT provides unambiguous information about the accuracy of methods/analytical systems.</p></div>\",\"PeriodicalId\":10172,\"journal\":{\"name\":\"Clinical biochemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical biochemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S000991202300228X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical biochemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000991202300228X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:雌二醇测量的准确性是很重要的,但当可能使用不可交换的样本和方法对等组均值是目标时,传统的能力测试(PT)无法评估准确性。需要对雌二醇测量进行基于准确性的评估。设计与方法从单个献血者中制备5份血清样本,冷冻后分发至76个纽约州卫生部(NYSDOH)认证的实验室。参与者分析样本中的雌二醇。根据美国疾病控制与预防中心(CDC)定义的目标,采用激素标准化计划(HoSt) E2性能标准(±12.5%)评估组均值偏差。每个实验室的表现采用总允许误差(接受限)进行评估,目标±25%或±15 pg/mL (55.1 pmol/L)(以较大者为准),目标±30%(临床实验室改进修正案[CLIA]),目标±26%(基于生物变异的最小限值[BV])。结果:雌二醇浓度分别为24.1、28.4、61.7、94.1和127 pg/mL,或88.5、104.3、226.5、245.4和466.2 pmol/L时,偏差(范围)分别为34%(-17%至175%)、40%(-33%至386%)、16%(-45%至193%)、5%(-27%至117%)和-4%(-31%至21%)。在低雌二醇浓度下,美国9种常用的方法/分析系统显示出较大的阳性方法/分析系统偏差。在9个分析系统中,0、0、3、7和6个系统对5种浓度的雌二醇样品符合HoSt标准。PT评估显示,当使用cdc定义的目标和NYSDOH、CLIA或BV标准时,分别有59%、69%和87%的实验室获得PT事件合格评分。然而,无论使用何种标准,如果使用方法同行组均值作为目标,>95%的实验室将获得PT合格分数。结论:需要提高雌二醇测量的准确性,特别是在雌二醇浓度低的情况下。基于准确性的PT提供了关于方法/分析系统准确性的明确信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Accuracy-based proficiency testing for estradiol measurements

Objectives

Accuracy of estradiol measurements is important but conventional proficiency testing (PT) cannot assess accuracy when possibly non-commutable samples are used and method peer-group means are the targets. Accuracy-based assessment of estradiol measurements is needed.

Design and Methods

Five serum samples were prepared from single donors, frozen, and distributed overnight to 76 New York State Department of Health (NYSDOH)-certified laboratories. Participants analyzed samples for estradiol. The biases of group means were assessed against the Centers for Disease Control and Prevention (CDC)-defined targets, evaluated using the Hormone Standardization Program (HoSt) E2 performance criterion of ±12.5 %. Each laboratory’s performance was evaluated using total allowable error (acceptance limits) of target ±25 % or ±15 pg/mL (55 pmol/L) (whichever was greater, NYSDOH), target ±30 % (Clinical Laboratory Improvement Amendments [CLIA]), and target ±26 % (minimal limit based on biological variation [BV]).

Results

The biases (range) were 34 % (−17 % to 175 %), 40 % (−33 % to 386 %), 16 % (−45 % to 193 %), 5 % (−27 % to 117 %), and −4% (−31 % to 21 %), for samples at estradiol of 24.1, 28.4, 61.7, 94.1, and 127 pg/mL, or 89, 104, 227, 345, and 466 pmol/L, respectively. Large positive method/analytical systematic biases were revealed for 9 commonly used method/analytical systems in the United States at low estradiol concentrations. Of the 9 analytical systems, 0, 0, 3, 7 and 6 met the HoSt criterion for the samples with estradiol at the five respective concentrations. PT evaluation showed that 59 %, 69 % and 87 % of laboratories would receive a PT event passing (satisfactory) score when the CDC-defined target and a criterion of NYSDOH, CLIA or BV was used, respectively. However, >95 % laboratories would obtain PT passing score if method peer-group means were used as targets regardless of the criterion used.

Conclusions

Improvement in accuracy of estradiol measurements is needed, particularly at low estradiol concentrations. Accuracy-based PT provides unambiguous information about the accuracy of methods/analytical systems.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical biochemistry
Clinical biochemistry 医学-医学实验技术
CiteScore
5.10
自引率
0.00%
发文量
151
审稿时长
25 days
期刊介绍: Clinical Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.
期刊最新文献
Deteriorated thiol-disulphide and oxidized-reduced glutathione status in blood in Alzheimer’s disease Editorial Board In vivo and in vitro relationship between ionized magnesium and ionized calcium Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes Serum glucose mediated association of serum lactate with acute kidney injury among AIS patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1